Child Health and Human Development Extramural Research Grants (Assistance Listing 93.865)
Administered by National Institutes of Health. An Assistance Listing is the permanent catalog entry for a federal funding program — individual opportunities are issued under it and come and go.
Overview
Assistance Listing 93.865 — Child Health and Human Development Extramural Research — is a federal funding program administered by National Institutes of Health. UseGrants has tracked 111 funding opportunities issued under it, of which 85 are accepting applications right now. A further 15 are forecast — announced by the agency but not yet open. The typical award ceiling is $375,000, with the largest at $6,250,000. Historically, opportunities under this listing post most often in June and May.
Eligibility is set per opportunity, not per listing. The free UseGrants check matches your organization type and focus against every open opportunity, including these.
- Open now
- 85
- Forecast
- 15
- Opportunities tracked
- 111
- Typical ceiling
- $375K
- Largest ceiling
- $6.3M
- Assistance Listing
- 93.865
Open opportunities under 93.865
85 opportunities are accepting applications, newest first. Confirm every detail on the issuing agency’s official listing before you apply.
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Due Feb 20, 2029National Institutes of Health · Amount varies
This NIH HEAL Initiative UG3/UH3 cooperative agreement funds preclinical optimization and development of safe, non-addictive small-molecule and biologic therapeutics for treating pain, advancing candidates toward Phase II trials. Applicants must already have a promising lead candidate, a strong biological rationale, and established assays. Foreign organizations and foreign components of U.S. organizations are not eligible to apply.
ResearchersSmall businessSchools & universitiesNarrow eligibilityPredoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)
Due Apr 8, 2029National Institutes of Health · Amount varies
This NIH Predoctoral-to-Postdoctoral Transition Award (F99/K00) supports promising graduate students as they finish doctoral research and move into mentored postdoctoral career development, in NIH mission-relevant fields. It is a mentored training award administered through institutions; candidates may not lead an independent clinical trial but may participate in a sponsor-led one. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed.
Schools & universitiesResearchersNarrow eligibilityNIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)
Due May 5, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25) funds hands-on research experiences that help build and diversify the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can provide the staff, facilities, and educational resources to run such programs, and proposed activities must be distinct from any existing federally funded training grants (such as T32). Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25) funds the development of courses, curricula, and educational methods that strengthen the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can commit staff, facilities, and educational resources, and proposed activities must be distinct from any existing federally funded training grants (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNovel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical Trial Optional)
Due Oct 2, 2026National Institutes of Health · Amount varies
This NIH (NICHD) P20 exploratory grant funds NExT AI Hubs studying how artificial intelligence technologies affect children diagnosed with or at risk for specific learning disabilities in reading, writing, and mathematics. Foreign organizations and foreign components are not eligible to apply; refer to the NOFO's eligibility section for the full list of eligible domestic applicants. A clinical trial is optional. No specific award amount is stated, and the program emphasizes building research infrastructure and early-career investigators.
ResearchersSchools & universitiesNarrow eligibilityBiological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)
Due May 7, 2029National Institutes of Health · Amount varies
This NIH (X01) opportunity does not provide cash funding but instead grants investigators access to services from a state-of-the-art Biological Testing Facility to advance contraceptive development or reproductive health research. Applicants do not need current NIH funding, though priority may go to programs already receiving NIH support. Notably, foreign organizations are eligible to apply, but foreign components of U.S. organizations and foreign components in general are not allowed. It suits researchers needing specialized biological testing resources.
ResearchersSchools & universitiesNarrow eligibilityResearch Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
Due Oct 25, 2027National Institutes of Health · Up to $375K
This NIH R15 (REAP) award funds small-scale research and student research experiences at health-professional and graduate schools that receive limited NIH funding, with a minimal-risk clinical trial required. Eligibility is restricted to degree-granting institutions that have received no more than $6 million per year of NIH support in 4 of the last 7 years; foreign organizations are not eligible. Awards reach up to about $375,000. The NIH-funding cap and institution-type limits make eligibility narrow, so verify your institution qualifies.
ResearchersSchools & universitiesNarrow eligibilityNIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Due Apr 5, 2027National Institutes of Health · Amount varies
This NIH STTR program (R41/R42) funds U.S. small businesses that partner with a nonprofit research institution to move scientific innovations toward commercialization. Eligibility is limited to U.S. small business concerns as defined by the SBA, and foreign organizations are not eligible. No award amount is listed.
Small businessNarrow eligibilityBRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
Due Oct 4, 2027National Institutes of Health · Amount varies
This NIH BRAIN Initiative U01 funds development of scalable technologies to map brain connectivity across scales in humans, non-human primates, and mice, feeding into the BRAIN CONNECTS network; no clinical trial is allowed. Eligibility is described in the funding notice, and foreign organizations and their U.S. components may apply. No award amount is specified. Funded projects must integrate into a coordinated network, so review the notice's eligibility details carefully.
ResearchersSchools & universitiesNarrow eligibilityNIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
Due Apr 5, 2029National Institutes of Health · Amount varies
This NIH SBIR Phase IIB award is restricted to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award; it bridges the gap between Phase II and commercialization for later-stage R&D. Only one such award is allowed per project, and applications must be submitted within the first six due dates after the Phase II budget period ends, so it is narrow and limited to existing grantees. Foreign organizations are not eligible to apply.
Small businessNarrow eligibilitySBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Due Apr 5, 2029National Institutes of Health · Amount varies
This NIH SBIR/STTR Commercialization Readiness Pilot (CRP) is restricted to U.S. small business concerns (as defined by the SBA) and helps move NIH-funded SBIR/STTR projects from late-stage development toward commercialization. It supports later-stage R&D and technical assistance such as replication studies, IND/IDE-enabling work, clinical studies, manufacturing scale-up, and regulatory support, and a significant portion may be subcontracted. Foreign organizations are not eligible to apply.
Small businessNarrow eligibilityNIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Due Apr 5, 2027National Institutes of Health · Amount varies
This NIH/CDC/FDA SBIR program (R43/R44) funds U.S. small businesses developing scientific innovations toward commercial products through feasibility and R&D studies. Eligibility is limited to U.S. small business concerns as defined by the SBA, and foreign organizations are not eligible. No award amount is listed.
Small businessNarrow eligibilityUsing Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)
Due Oct 20, 2028National Institutes of Health · Up to $200K
This NIH R21 grant funds secondary analyses that use archived HIV/AIDS data sets and specimen collections to answer questions about maternal, pediatric, and adolescent HIV/AIDS. Both U.S. and foreign organizations are eligible to apply, but foreign components within a project are not allowed. The award ceiling is up to about $200,000.
ResearchersSchools & universitiesBroad eligibilityLimited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P50 Clinical Trial Optional)
Due Oct 2, 2026National Institutes of Health · Up to $800K
This NIH (NICHD) P50 award funds Intellectual and Developmental Disabilities Research Centers. It is a limited competition: only current recipients of IDDRC P50 awards under RFA-HD-20-016 or RFA-HD-21-009 are eligible to apply, so new applicants do not qualify. Foreign organizations and foreign components are not eligible. A clinical trial is optional, and the stated maximum is about $800,000 for centers running three years.
Schools & universitiesResearchersLarge awardNarrow eligibilityINCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)
Due Jun 15, 2028National Institutes of Health · Amount varies
Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH R61/R33 funds milestone-driven development of clinical trials to treat co-occurring health conditions in people with Down syndrome — up to two years of planning followed by up to three years of trial support. Clinical trials are required.
ResearchersSchools & universitiesNonprofitsGovernment / tribalINCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)
Due Jun 15, 2028National Institutes of Health · Up to $500K
Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH R01 funds groundbreaking, high-impact Down syndrome research across any relevant topic, with no preliminary data required. Awards up to about $500,000.
ResearchersSchools & universitiesNonprofitsGovernment / tribal+1 moreINCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)
Due Jun 15, 2028National Institutes of Health · Up to $200K
Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH R21 funds exploratory, higher-risk Down syndrome research — feasibility studies, novel methods, or new applications of existing techniques. Awards up to about $200,000.
ResearchersSchools & universitiesNonprofitsGovernment / tribalBioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
Due Jul 5, 2029National Institutes of Health · Up to $500K
This NIH (R01) Bioengineering Research Grant funds multidisciplinary projects that apply engineering approaches to biomedical, clinical, or translational problems, with a stated budget up to about $500,000. It supports clinical trials that validate performance but excludes Phase III trials, conventional non-translational trials, and commercial production. Eligibility is relatively broad for an NIH grant: both foreign organizations and foreign components of U.S. organizations are eligible to apply, though foreign components (as defined by NIH) are not allowed.
ResearchersSchools & universitiesLarge awardBRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)
Due Feb 11, 2027National Institutes of Health · Up to $700K
An NIH BRAIN Initiative R61 funding exploratory human neuroscience using invasive neural recording and stimulation during surgical procedures. Foreign organizations and foreign components are not eligible; the work requires multidisciplinary teams with access to neurosurgical settings. Awards reach up to about $700,000, and clinical trials are not allowed. This is a highly specialized research award for institutions with relevant clinical/research capacity, not for general nonprofits, small businesses, or individuals.
ResearchersSchools & universitiesLarge awardNarrow eligibilityAdministrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Due Nov 30, 2028National Institutes of Health · Amount varies
This NIH opportunity provides administrative supplements only to organizations that already hold an active, eligible NIH grant or cooperative agreement, to cover unforeseen increased costs within the scope of the existing project. New applicants without a current NIH award cannot use it. Funding is not guaranteed, and applicants must discuss requests with the awarding Institute's staff before submitting; foreign organizations may apply only consistent with the existing parent award.
ResearchersSchools & universitiesNarrow eligibilityClinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Due Jul 20, 2028National Institutes of Health · Amount varies
Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R21 funds projects that improve clinical-trial readiness for rare diseases — developing biomarkers and outcome measures, or characterizing a disease's course to enable future trials. Award size follows standard R21 limits.
ResearchersSchools & universitiesNonprofitsGovernment / tribalBRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
Due Nov 8, 2027National Institutes of Health · Amount varies
This NIH BRAIN Initiative R01 funds development of computational theories, models, and methods for analyzing complex brain-circuit data, to be shared with the research community. Eligible applicants are research organizations, including faith- or community-based organizations, tribal governments, foreign organizations, and U.S. territories; it targets institutions rather than individuals. No award amount is specified. The work is narrowly scoped to neural-circuit tool building, so confirm fit before applying.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreStephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
Due Aug 25, 2028National Institutes of Health · Amount varies
Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R01 supports early-stage investigators pursuing a new research direction, and applications must include no preliminary data. Award size follows standard R01 limits; aimed at researchers early in their independent careers.
ResearchersSchools & universitiesNonprofitsGovernment / tribalExpanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
Due Feb 17, 2028National Institutes of Health · Amount varies
Open to U.S. universities, research institutions, nonprofits, and certain government and tribal organizations; foreign organizations are not eligible. This NIH R21 funds exploratory, early-stage projects developing methods or agents to target 'undruggable' molecules in serious diseases. Award size isn't specified and follows standard NIH R21 limits; best suited to researchers pursuing high-risk, innovative therapeutics.
ResearchersSchools & universitiesNonprofitsGovernment / tribalBlueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
Due Jan 28, 2028National Institutes of Health · Amount varies
This NIH program (Blueprint MedTech Translator) funds translational research and clinical feasibility studies for therapeutic and diagnostic devices targeting nervous- or neuromuscular-system disorders, open to a broad range of institutions including HBCUs, Hispanic-serving institutions, tribal colleges, faith- and community-based organizations, and individuals or businesses developing their own devices. It is a milestone-driven cooperative agreement requiring NIH staff involvement in project planning and monitoring. No award amount is specified, and the deadline is not imminent.
NonprofitsSmall businessResearchersSchools & universities+1 moreSupport for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
Due Sep 7, 2028National Institutes of Health · Up to $100K
This NIH award (SuRE, up to $100,000) funds investigator-initiated biomedical research by full-time faculty at resource-limited higher education institutions who do not currently hold other NIH research project grants, aiming to build research capacity and student research experience. Foreign organizations and their non-U.S. components are not eligible. The maximum award is under $100,000, and the application deadline is not imminent.
Schools & universitiesResearchersSmall awardNarrow eligibilitySupport for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
Due Sep 7, 2028National Institutes of Health · Up to $125K
This NIH award (SuRE-First, up to $125,000) funds investigator-initiated biomedical research by full-time faculty at resource-limited institutions who have never previously held an independent, peer-reviewed external research grant, aiming to build research capacity and provide student research experience. Foreign organizations and their non-U.S. components are not eligible. The maximum award is small, and the deadline is not imminent.
Schools & universitiesResearchersSmall awardNarrow eligibilityRuth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
Due May 7, 2028National Institutes of Health · Amount varies
This NIH fellowship supports predoctoral students pursuing a combined MD/PhD or similar dual-doctoral degree at institutions that lack an NIH-funded dual-degree training program, aiming to prepare them for physician-scientist careers. It applies to individual students, not organizations, and excludes foreign organizations and their non-U.S. components; applicants cannot lead an independent clinical trial. No funding amount is given, and the deadline is not imminent.
ResearchersIndividualsNarrow eligibilityRuth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
Due May 7, 2028National Institutes of Health · Amount varies
This NIH fellowship funds individual postdoctoral researchers who show strong potential to become independent investigators in health-related research fields, supporting mentored research training. It is an individual award (not for organizations), and foreign organizations are listed as an other-eligible applicant category. No specific funding amount is given, and the deadline is not imminent.
ResearchersIndividualsNarrow eligibilityRuth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
Due May 7, 2028National Institutes of Health · Amount varies
This NIH fellowship supports predoctoral students in combined MD/PhD or similar dual-doctoral degree programs at institutions that already have an NIH-funded dual-degree training program, preparing them for physician-scientist careers. It is limited to individual student applicants; foreign organizations and their non-U.S. components are not eligible, and applicants may not lead an independent clinical trial. No award amount is listed, and the deadline is not imminent.
ResearchersIndividualsNarrow eligibilityRuth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)
Due May 7, 2028National Institutes of Health · Amount varies
This NIH fellowship funds individual predoctoral students conducting dissertation research in health-related fields under a faculty sponsor, with the goal of developing them into independent researchers. It is limited to individual applicants (not organizations); foreign organizations are named as an other-eligible category, and applicants may not lead an independent clinical trial. No specific award amount is listed, and the deadline is several years out.
ResearchersIndividualsNarrow eligibilityIntervention Research to Improve Native American Health (R01 Clinical Trial Optional)
Due Jan 7, 2027National Institutes of Health · Amount varies
This NIH R01 funds larger-scale research testing and disseminating interventions to improve health in Native American populations, following the same research focus as its companion R34 announcement. Eligible applicants include universities, tribal colleges, minority-serving institutions, and community organizations, with foreign entities restricted. No award amount is specified.
ResearchersBroad eligibilityIntervention Research to Improve Native American Health (R34 Clinical Trial Optional)
Due Jan 7, 2027National Institutes of Health · Amount varies
This NIH R34 funds early-stage research and pilot studies testing interventions to improve health outcomes in Native American communities, including etiologic research and culturally-informed treatment studies. Eligible applicants include universities, tribal colleges, minority-serving institutions, and community organizations, with some restrictions on foreign entities. No award amount is specified; a clinical trial component is optional.
ResearchersBroad eligibilityEthical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
Due Nov 18, 2026National Institutes of Health · Amount varies
This NIH R01 grant funds research applications studying the ethical, legal, and social implications of human genetics and genomics, using empirical, conceptual, legal, or normative methods. Applications must include a Plan for Enhancing Diverse Perspectives (PEDP); those without one won't be reviewed. It's aimed at eligible U.S. and territorial research institutions, and the deadline is November 18, 2026.
ResearchersSchools & universitiesNarrow eligibilityEthical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
Due Nov 16, 2026National Institutes of Health · Up to $50K
This NIH grant (up to $50,000) funds small research projects studying the ethical, legal, and social implications (ELSI) of human genetics and genomics, including single-investigator studies, preliminary data collection, and secondary data analysis. It's aimed at eligible U.S. and territorial research institutions. The deadline is November 16, 2026.
ResearchersSmall awardNarrow eligibilityEthical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Due Nov 18, 2026National Institutes of Health · Amount varies
This NIH R21 grant funds exploratory and developmental research into the ethical, legal, and social implications of human genetics and genomics, particularly studies examining new or emerging genomic technologies. It's open to eligible U.S. and territorial research institutions using empirical, conceptual, legal, or normative methods. The deadline is November 18, 2026.
ResearchersSchools & universitiesNarrow eligibilityHEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
Due Nov 23, 2026National Institutes of Health · Up to $375K
NIH HEAL Initiative R15 funding for basic or mechanistic pain research at institutions eligible for the R15 (Research Enhancement) mechanism, which targets schools and components that have not been major NIH recipients. Aimed at engaging undergraduate, graduate, and health-professional trainees in the research; foreign organizations are not eligible. The listed maximum is about $375,000. R15 eligibility rules restrict which institutions can apply, so eligibility is narrow.
ResearchersSchools & universitiesNarrow eligibilityEarly Immune System Development and Ontogeny (R01 Clinical Trial Optional)
Due Nov 5, 2028National Institutes of Health · Up to $400K
This NIH R01 grant funds research into early immune system development from the prenatal period through early childhood, including effects of in-utero HIV or antiretroviral exposure. A broad range of applicants is eligible, including colleges and universities, tribal governments, faith- and community-based organizations, minority-serving institutions, and foreign organizations. The award ceiling is up to about $400,000.
ResearchersSchools & universitiesNonprofitsGovernment / tribal+1 moreNIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $50K
The NIH parent Small Research Grant (R03, clinical trial not allowed) supports small, short-term projects such as pilot and feasibility studies, secondary data analysis, and methodology development. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. The award is capped at about $50,000. The small budget suits research institutions pursuing limited-scope projects to generate preliminary data.
ResearchersSchools & universitiesGovernment / tribalNonprofits+2 moreNIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
Due Jan 7, 2028National Institutes of Health · Amount varies
The NIH parent Exploratory/Developmental Research Grant (R21, clinical trial required) supports early-stage research projects with at least one clinical trial, aligned with participating NIH institutes' missions. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. No specific award amount is stated. The clinical-trial requirement makes this best suited to research institutions with trial capacity.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreNIH Research Project Grant (Parent R01 Clinical Trial Required)
Due Jan 7, 2028National Institutes of Health · Amount varies
The NIH parent Research Project Grant (R01, clinical trial required) supports investigator-initiated research projects, with at least one clinical trial required, aligned with participating NIH institutes' missions. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. No specific award amount is stated. The clinical-trial requirement makes this best suited to research institutions with trial capacity.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreNIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
The NIH parent Exploratory/Developmental Research Grant (R21, clinical trial not allowed) supports early-stage, higher-risk research projects that may lead to breakthroughs or novel methods. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. No specific award amount is stated. This is an exploratory research mechanism aimed at research institutions.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreNIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
The NIH parent Research Project Grant (R01, clinical trial not allowed) supports investigator-initiated research projects aligned with participating NIH institutes' missions, excluding clinical trials. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. No specific award amount is stated. This is a core NIH research mechanism aimed at research institutions.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreLeveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
Due Nov 15, 2027National Institutes of Health · Up to $6.3M
This NIH award lets investigators use NICHD's existing clinical research network infrastructure to run multisite trials and studies on infant, child, women's, and disability health, structured as a start-up phase followed by full enrollment. Applications must be submitted jointly with an NICHD-supported network Data Coordinating Center, which narrows this to investigators already positioned within that network. Awards can reach up to $6,250,000.
ResearchersLarge awardNarrow eligibilityLimited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
Due Oct 19, 2027National Institutes of Health · Up to $650K
This NIH limited-competition award (UG3/UH3) funds collaborative innovation projects within the CTSA Program consortium to accelerate translational research. Eligibility is restricted per the funding notice, and foreign organizations and their U.S. components are not eligible, so this is aimed at institutions already in or aligned with the CTSA consortium rather than the general public. Awards run up to roughly $650,000. Review the notice's eligibility section closely, as access is limited.
ResearchersSchools & universitiesLarge awardNarrow eligibilityResearch Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $375K
The REAP program funds small-scale research at health professional and graduate schools that haven't been major recipients of NIH support, while giving students hands-on research experience. Eligibility is limited to institutions awarding NIH-relevant degrees that received under $6 million per year in NIH support in 4 of the last 7 years — a specific financial threshold worth checking before applying. Awards go up to $375,000.
ResearchersSchools & universitiesNarrow eligibilityInnovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Due Nov 16, 2027National Institutes of Health · Up to $200K
This NIH (R21) opportunity funds research developing novel screening approaches or therapies for fatal or disabling conditions identified through newborn screening, including high-priority genetic conditions. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. The maximum award is about $200,000.
ResearchersSchools & universitiesNarrow eligibilityAcademic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $375K
An NIH Academic Research Enhancement Award (AREA/R15) for undergraduate-focused institutions that do not receive substantial NIH funding, supporting small-scale biomedical research with undergraduate involvement. Eligibility is narrow: institutions must award baccalaureate science degrees and have received no more than about $6 million per year of NIH support in 4 of the last 7 years; foreign organizations are not eligible. The award is capped at about $375,000. This is restricted to qualifying lower-NIH-funded undergraduate institutions.
ResearchersSchools & universitiesNarrow eligibilityInnovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
Due Nov 16, 2027National Institutes of Health · Amount varies
This NIH (R01) opportunity funds research developing novel screening approaches or therapies for fatal or disabling conditions identified through newborn screening, including high-priority genetic conditions. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityNew Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH exploratory research grant (R21) funds high-risk, highly novel approaches to measuring brain changes across the lifespan, including studies that may lack preliminary data. It is aimed at multidisciplinary researchers at eligible institutions such as universities, nonprofits, tribal organizations, and government agencies. No award amount is listed.
ResearchersSchools & universitiesBroad eligibilityNew Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH research grant supports new or novel methods to measure brain activity, connectivity, or genomics across the lifespan to study neurodevelopment and aging. It is intended for multidisciplinary researchers at eligible institutions such as universities, nonprofits, tribal organizations, and government agencies. No award amount is listed and the eligibility text does not specify a dollar cap.
ResearchersSchools & universitiesBroad eligibilityAcademic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH AREA (R15) award funds small-scale research at undergraduate-focused institutions that receive limited NIH funding, emphasizing undergraduate research experiences; a minimal-risk clinical trial is required. Eligible institutions must grant baccalaureate science degrees and have received no more than about $6 million per year of NIH support in 4 of the last 7 years; foreign organizations are not eligible. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityNCMRR Early Career Research Award (R03 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Up to $200K
An NIH/NCMRR Early Career Research Award (R03, clinical trial optional) supporting basic and clinical rehabilitation research from scientists establishing independent careers, intended to generate preliminary data for a later R01. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. The award is capped at about $200,000. This is an early-career research mechanism administered through a sponsoring institution.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreAdvancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
Due Sep 7, 2027National Institutes of Health · Amount varies
This NIH (R21) opportunity supports exploratory community-engaged research to develop novel, culturally and linguistically responsive measures of children's language development and supportive environmental factors. Eligible applicants are research organizations including universities, colleges, government and tribal entities, and faith- or community-based organizations; it targets established research teams rather than individuals or general nonprofits. Award amounts are not specified. Confirm program-specific eligibility in the full announcement.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityAdvancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
Due Sep 7, 2027National Institutes of Health · Amount varies
This NIH (R01) opportunity funds community-engaged research to develop novel, culturally and linguistically responsive measures of children's language development and the environmental factors that support it. Eligible applicants are research organizations including universities, colleges, government and tribal entities, and faith- or community-based organizations; it is intended for established research teams rather than individuals or general nonprofits. Award amounts are not specified. Confirm program-specific eligibility in the full announcement.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityNICHD Small Research Grant Program (R03 Clinical Trial Required)
Due Jan 7, 2028National Institutes of Health · Up to $50K
An NIH/NICHD Small Research Grant (R03, clinical trial required) supporting small clinical-trial projects within the NICHD mission. Eligible applicants include a broad range of domestic and foreign institutions such as universities, tribal governments, and community-based organizations. The award is capped at about $50,000. The small budget and clinical-trial requirement make this best suited to research institutions running limited-scope pilot trials.
ResearchersSchools & universitiesGovernment / tribalNonprofits+2 moreRuth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
Due May 4, 2028National Institutes of Health · Amount varies
This NIH training grant funds domestic institutions of higher education (including HBCUs, Hispanic-serving institutions, and tribal colleges) to build predoctoral and postdoctoral biomedical research training programs, not individual researchers directly. Eligibility is fairly broad among institution types, but non-domestic entities and their foreign components are excluded, and the program does not support short-term-only training plans. No dollar amount is listed, and the deadline is not near-term.
Schools & universitiesBroad eligibilityBRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
Due Feb 8, 2027National Institutes of Health · Amount varies
An NIH BRAIN Initiative R01 funding the development and validation of novel tools to study cell-type- and circuit-specific processes in the brain. Eligibility is geared toward research institutions, including HBCUs, Hispanic-serving and Tribal colleges, and foreign organizations; this is a federal research grant, not a fit for typical nonprofits, small businesses, or individuals without an academic/research affiliation. No award amount is specified. Clinical trials are not allowed under this opportunity.
ResearchersSchools & universitiesNarrow eligibilityNatural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH R01 funds research into the natural history of conditions that are or could become part of newborn screening programs, to inform earlier and better-targeted treatment. Eligible applicants include universities, minority- and tribal-serving institutions, and similar research organizations. No award amount is specified.
ResearchersBroad eligibilityBRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
Due Sep 28, 2026National Institutes of Health · Amount varies
This NIH BRAIN Initiative program (UG3/UH3) is a milestone-driven cooperative agreement supporting translational development and small clinical studies of next-generation therapeutic and diagnostic devices for nervous and neuromuscular disorders. Eligible applicants are institutions, including minority-serving institutions, HBCUs, and tribal colleges; foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components are otherwise allowed. NIH program staff participate in project planning and monitoring. No award amount is stated; eligibility centers on research institutions able to develop and test devices.
Schools & universitiesResearchersNarrow eligibilityBRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
Due Sep 28, 2026National Institutes of Health · Amount varies
This NIH BRAIN Initiative program (UH3) funds small clinical trials to advance next-generation devices for recording and modulating the human central nervous system. Eligible applicants are institutions, including minority-serving institutions, HBCUs, and tribal colleges; foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components are otherwise allowed. No award amount is stated. This is a clinical-research mechanism aimed at research institutions capable of conducting device trials.
Schools & universitiesResearchersNarrow eligibilityDissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH R21 funds exploratory research on dissemination and implementation strategies for evidence-based health interventions, including studies on de-implementing low-value practices. Eligible applicants include universities and similar research institutions across NIH's mission areas. No award amount is specified.
ResearchersBroad eligibilityScreening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
An NIH research project grant (R01, clinical trial not allowed) supporting screening and functional validation of genomic variants linked to human congenital anomalies, developmental disabilities, and inborn errors of metabolism. A broad set of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. No specific award amount is stated. This is a basic-science genomics mechanism for research institutions.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreDissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH R03 provides smaller, shorter-term funding for research on dissemination and implementation strategies — helping evidence-based health practices get adopted and sustained, or ineffective ones phased out. Eligible applicants include universities and similar research institutions across NIH's mission areas. No award amount is specified, though R03 awards are typically modest.
ResearchersBroad eligibilityDissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH R01 funds research identifying and testing strategies to help evidence-based health interventions get adopted, scaled, and sustained — or, conversely, to phase out ineffective practices. Eligible applicants include universities, minority- and tribal-serving institutions, and similar research organizations across NIH's mission areas. No award amount is specified.
ResearchersBroad eligibilityBRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)
Due Jun 15, 2027National Institutes of Health · Amount varies
This NIH BRAIN Initiative (U01) program funds development of next-generation sensors and bioelectronic devices that synchronize with brain recordings to build computational models of human and animal behavior. Eligible applicants are research organizations including universities, colleges, government and tribal entities, and faith- or community-based organizations; it targets established research and technology-development teams, not individuals or general nonprofits. Award amounts are not specified. Confirm program-specific eligibility in the full announcement.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityBRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)
Due Jun 15, 2027National Institutes of Health · Amount varies
This NIH BRAIN Initiative (U24) program funds establishment of facilities at minority-serving institutions and IDeA-eligible institutions to produce and distribute brain cell type-specific research reagents to the neuroscience community. Eligibility is narrowed to minority-serving and IDeA-eligible U.S. institutions; foreign organizations and non-U.S. components are not eligible to apply, though some foreign components are allowed. It is intended for qualifying research institutions, not individuals or general nonprofits, and awardees must coordinate with existing Armamentarium project teams. Award amounts are not specified.
ResearchersSchools & universitiesNarrow eligibilityNICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)
Due Sep 25, 2027National Institutes of Health · Amount varies
This NIH (NICHD, P41) program supports continued operation, maintenance, and dissemination of bioinformatics database resources important to research using animal models of embryonic development. Eligible applicants are U.S. research organizations including universities, government and tribal entities, and faith- or community-based organizations; foreign organizations and non-U.S. components of U.S. organizations are not eligible. It is intended for institutions that operate established bioinformatics resources, not individuals or general nonprofits. Award amounts are not specified.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityHEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
Due Jan 15, 2027National Institutes of Health · Up to $350K
This NIH HEAL Initiative R61/R33 funds early translational drug-discovery research toward non-addictive pain therapeutics, including assay development, screening, and initial characterization of candidate agents; no clinical trial is allowed. Eligible applicants include universities, research institutions, and tribal and community organizations, but foreign organizations are not eligible to apply. The maximum award is about $350,000. It requires drug-discovery research capacity.
ResearchersSchools & universitiesGovernment / tribalSmall award+1 moreNIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
Due Dec 4, 2026National Institutes of Health · Amount varies
This NIH R50 award provides salary support for established Research Software Engineers who build and disseminate biomedical software, tools, and algorithms. Eligible applicants include universities and research institutions; foreign (non-U.S.) organizations are not eligible to apply. It is tied to an existing research environment and specialized staff, so it suits research institutions rather than general nonprofits or individuals applying on their own. No specific award amount is stated.
ResearchersSchools & universitiesBroad eligibilitySuccessor-in-Interest (Type 6 Parent Clinical Trial Optional)
Due Jul 17, 2027National Institutes of Health · Amount varies
This NIH mechanism is narrowly limited to organizations that already hold specific NIH grants and need to transfer an award due to a change in organizational status (successor-in-interest). It is an administrative prior-approval request, not a new funding opportunity, and approval of the transfer is not guaranteed. Only current NIH grantee organizations should use it; it does not apply to individuals, new applicants, or general nonprofits. No award amount applies.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityChange of Recipient Organization (Type 7 Parent Clinical Trial Optional)
Due Jul 12, 2027National Institutes of Health · Amount varies
This NIH mechanism is narrowly limited to organizations that already hold specific types of NIH grants and need to transfer an existing award to a new recipient institution (a change of recipient organization). It is an administrative prior-approval request, not a new funding opportunity, and there is no guarantee a transfer will be approved. Only current NIH grantee organizations should apply; it does not apply to individuals, new applicants, or general nonprofits. No award amount applies.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityAcademic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
Due Jan 7, 2027National Institutes of Health · Up to $375K
This NIH R15 (AREA) award supports small-scale research at undergraduate-focused institutions that receive limited NIH funding, with a required clinical trial. Eligibility is restricted to institutions that award baccalaureate science degrees and have received no more than $6 million/year of NIH support in 4 of the last 7 years; foreign organizations are not eligible to apply. The maximum award is about $375,000. This is narrowly targeted at less-research-intensive degree-granting institutions.
ResearchersSchools & universitiesSmall awardNarrow eligibilityMentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH mentored research scientist award (K01) provides three to five years of protected, supervised career development leading to research independence; this version does not allow leading an independent clinical trial. It is intended for individual investigators applying through eligible institutions such as universities. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityNIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH Pathway to Independence award (K99/R00) supports outstanding postdoctoral researchers transitioning to independent faculty positions; this version does not allow leading an independent clinical trial. It is intended for individual early-career investigators applying through eligible institutions such as universities; foreign organizations cannot apply. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)
Due May 8, 2027National Institutes of Health · Amount varies
This NIH mentored career development award (K08) prepares individuals with a clinical doctoral degree for research careers through supervised biomedical, behavioral, or translational research; this version does not allow leading an independent clinical trial. It is intended for individual clinician-investigators applying through eligible institutions such as universities and academic medical centers. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH mentored research scientist award (K01) provides three to five years of protected, supervised career development in biomedical, behavioral, or clinical research leading to independence, and this version requires an independent clinical trial. It is intended for individual investigators applying through eligible institutions such as universities. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)
Due May 8, 2027National Institutes of Health · Amount varies
This NIH mentored career development award (K08) prepares individuals with a clinical doctoral degree for research careers through supervised biomedical, behavioral, or translational research, and this version requires an independent clinical trial. It is intended for individual clinician-investigators applying through eligible institutions such as universities and academic medical centers. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityNIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
Due May 7, 2027National Institutes of Health · Amount varies
The NIH K99/R00 Pathway to Independence Award supports postdoctoral researchers transitioning to independent faculty positions, covering a mentored phase followed by several years of independent research funding. Applications are submitted through eligible research institutions — universities, minority-serving colleges, and similar organizations — on behalf of the individual awardee. No award amount is specified, and a clinical trial component is required for this version.
ResearchersBroad eligibilityMentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
Due May 7, 2027National Institutes of Health · Amount varies
The NIH K25 award supports quantitative scientists and engineers (e.g., in math, statistics, computer science, or physics) who want to redirect their research toward NIH-relevant health questions, providing protected time for mentored study. It's submitted through eligible research institutions on behalf of an individual investigator, and excludes those leading an independent clinical trial. No award amount is specified.
ResearchersBroad eligibilityMentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH mentored career development award (K25) supports quantitative or engineering scientists redirecting their work toward health research, providing protected research time under a mentor; this version requires the applicant to lead an independent clinical trial. It is intended for individual investigators applying through eligible institutions such as universities. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)
Due May 8, 2027National Institutes of Health · Amount varies
This NIH mentored career development award (K23) supports individuals with a clinical doctoral degree committed to patient-oriented research, providing protected research time under mentorship, and this version requires an independent clinical trial. It is intended for individual clinician-investigators applying through eligible institutions such as universities and academic medical centers. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH mentored career development award (K23) supports individuals with a clinical doctoral degree who are committed to patient-oriented research, providing protected research time under mentorship. This version does not allow leading an independent clinical trial. It is intended for individual clinician-investigators applying through eligible institutions such as universities and academic medical centers. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityBRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
Due Jan 28, 2027National Institutes of Health · Up to $750K
An NIH BRAIN Initiative R18 funding preclinical proof-of-concept work on novel recording and modulation technologies for the human central nervous system, up to readiness for first-in-human studies. The eligibility text is mixed but states foreign organizations and foreign components are not eligible to apply, while domestic research institutions, minority-serving and Tribal colleges may. Awards reach up to about $750,000, and clinical trials are not allowed. This is a specialized research award, not a fit for general nonprofits, small businesses, or individuals.
ResearchersSchools & universitiesLarge awardNarrow eligibilityCompeting Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
Due Nov 24, 2026National Institutes of Health · Amount varies
NIH mechanism allowing existing award recipients to apply for revision (supplemental) funding to expand a current NIH grant or cooperative agreement, only in response to a specific Notice of Special Interest. Restricted to organizations that already hold an active NIH single-project award. No award amount is specified. Because applicants must already be NIH grantees and respond to a matching NOSI, eligibility is narrow and not open to new applicants.
ResearchersSchools & universitiesNarrow eligibility
Forecast opportunities under 93.865
15 opportunities have been announced by the issuing agency but are not accepting applications yet. Forecast notices usually carry no deadline and no application package until they post.
Previously issued under this listing
Past rounds are the best guide to what the next one will look like — the scope, the award size, and the time of year it lands.
When 93.865 opportunities post
Across the 111 opportunities UseGrants has tracked under this listing, postings cluster in June, May, November, December. Federal program cycles repeat, so a listing that missed you this year is worth watching for the next round.
- June22 opportunities
- May18 opportunities
- November16 opportunities
- December13 opportunities
What is Assistance Listing 93.865?
93.865 is the federal Assistance Listing (formerly CFDA) number for Child Health and Human Development Extramural Research, administered by National Institutes of Health. An Assistance Listing is the permanent catalogue entry for a funding program; individual notices of funding opportunity are issued under it, each with its own deadline and eligibility. UseGrants has tracked 111 such notices.
Are there open 93.865 grants right now?
Yes — 85 opportunities are currently accepting applications under 93.865, listed on this page with their deadlines and award amounts. 15 more are forecast: announced, but not yet open to applicants. Verify each on the issuing agency's official listing before you apply.
How much funding do 93.865 grants award?
The typical award ceiling for an opportunity under 93.865 is $375,000, ranging up to $6,250,000. Award floors and ceilings are set per opportunity — check the specific notice you intend to apply to.
Which agencies issue grants under 93.865?
National Institutes of Health has issued the opportunities UseGrants tracks under this listing. UseGrants is an independent aggregator compiling public Grants.gov records — always confirm current details on the agency's own listing.
Who applies to 93.865, and what it sits alongside
Related federal programs
Source: public Grants.gov opportunity records. Assistance Listing numbers and program titles are as published by the issuing agency. UseGrants is an independent aggregator, not a federal agency — always confirm the current deadline, eligibility and award amount on the official listing before you apply.